Related Experiment Videos
Persistent vaginitis caused by metronidazole-resistant trichomonas
1Department of Obstetrics-Gynecology, George Washington University School of Medicine and Health Sciences, Washington, DC.
Obstetrics and Gynecology
|September 1, 1990
Summary
Persistent trichomoniasis, a resistant form of trichomonal vaginitis, can be challenging to treat. An innovative combination of oral and topical therapies offers a potential solution for persistent cases.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Trichomoniasis, caused by Trichomonas vaginalis, is a common sexually transmitted infection.
- Persistent or recurrent trichomoniasis is often attributed to noncompliance or reinfection.
- Drug resistance to standard treatments like metronidazole is an emerging concern.
Observation:
- Two cases of exceptionally persistent and prolonged trichomonal vaginitis were observed.
- These cases were refractory to multiple conventional treatment regimens, including parenteral metronidazole.
- Standard therapeutic approaches failed to resolve the infections.
Findings:
- An unconventional treatment strategy was implemented, combining oral and topical therapeutic agents.
- This combined approach led to successful clinical and microbiologic resolution of the infection in both patients.
- The study demonstrates the efficacy of a novel therapeutic combination.
Implications:
- This approach may offer a viable alternative for managing drug-resistant or persistent trichomoniasis.
- Further research is warranted to validate this treatment strategy in a larger patient cohort.
- Understanding and addressing metronidazole resistance in Trichomonas vaginalis is crucial for effective treatment.